Evidence map›Paper›PMID 31387970›Full record

Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2019

Financial Incentives to Promote Colorectal Cancer Screening: A Longitudinal Randomized Control Trial.

Alicea Lieberman, Ayelet Gneezy, Emily Berry, Stacie Miller, Mark Koch, Chul Ahn, Bijal A Balasubramanian, Keith E Argenbright, Samir Gupta

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06929481 (Screening With Liquid Biopsies to Address Colorectal Cancer Inequities), which is not on this map. Cited by 10 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06929481 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Screening With Liquid Biopsies to Address Colorectal Cancer Inequities

TypeinterventionalSponsorUniversity of California, San DiegoRan2025 to 2026Enrolled340ConditionsColorectal Cancer Screening, Colorectal Cancer (CRC)ArmsCell free DNA (cfDNA) blood test, At home Fecal Immunochemical Test (FIT) or Colonoscopy
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Evaluating colonoscopy quality by performing provider type.Journal of the National Cancer Institute · 2024
    Article
  8. Review
  9. What Multilevel Interventions Do We Need to Increase the Colorectal Cancer Screening Rate to 80%?Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2021
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alicea LiebermanRady School of Management, University of California San Diego, La Jolla, California.
Ayelet GneezyRady School of Management, University of California San Diego, La Jolla, California.
Emily BerryUniversity of Texas Southwestern Medical Center, Moncrief Cancer Institute, Fort Worth, Texas.
Stacie MillerUniversity of Texas Southwestern Medical Center, Moncrief Cancer Institute, Fort Worth, Texas.
Mark KochDepartment of Family Medicine, John Peter Smith Health Network, Fort Worth, Texas.
Chul AhnUniversity of Texas Southwestern Medical Center, Harold C. Simmons Cancer Center, Dallas, Texas.
Bijal A BalasubramanianDepartment of Epidemiology, Genetics, & Environmental Science, UT Health School of Public Health, Dallas, Texas.
Keith E ArgenbrightUniversity of Texas Southwestern Medical Center, Moncrief Cancer Institute, Fort Worth, Texas.
Samir GuptaSan Diego Veterans Affairs Healthcare System, San Diego, California. s1gupta@ucsd.edu.

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
NCI NIH HHS P30 CA023100
6 · The paper itself

Abstract

backgroundFinancial incentives may improve health behaviors. We tested the impact of offering financial incentives for mailed fecal immunochemical test (FIT) completion annually for 3 years.

methodsPatients, ages 50 to 64 years, not up-to-date with screening were randomized to receive either a mailed FIT outreach (

resultsYear 1 FIT completion was 36.9% with incentives versus 36.2% outreach alone (

conclusionsOffering small incentives did not increase FIT completion relative to standard outreach. IMPACT: This was the first longitudinal study testing the impact of repeated financial incentives, and their withdrawal, on FIT completion.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerFemaleHumansLongitudinal StudiesMaleMiddle Aged

Identifiers

PMID31387970
PMCPMC7008465

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.